Data / Drug companies / Norethindrone
Norethindrone: 17 companies and 22 products in the FDA NDC directory
Norethindrone is listed in the FDA National Drug Code Directory by 17 companies, with 22 products in commercial distribution. 21 of the products (95.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet; kit, and the newest product started marketing on January 29, 2025.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 17
- Products
- 22
- Generic (ANDA) products
- 21 (95.5%)
- Application numbers
- 15
- Routes
- Oral
- Brand names
- Errin, Lyleq, Jencycla, Incassia, Sharobel, Emzahh, Heather, Meleya
- openFDA record search
- api.fda.gov
Companies that list norethindrone
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Dr. Reddy's Laboratories Inc. | 2 | tablet | Generic drugs (ANDA) | May 6, 2024 |
| Glenmark Pharmaceuticals Inc., USA | 2 | tablet | Generic drugs (ANDA) | November 3, 2010 |
| Lupin Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | November 11, 2020 |
| NorthStar Rx LLC | 2 | kit | Generic drugs (ANDA) | September 13, 2013 |
| Xiromed, LLC | 2 | tablet | Generic drugs (ANDA) | January 29, 2025 |
| A-S Medication Solutions | 1 | tablet | Generic drugs (ANDA) | November 11, 2020 |
| Afaxys Pharma, LLC | 1 | tablet | Generic drugs (ANDA) | September 23, 2016 |
| Amneal Pharmaceuticals LLC | 1 | tablet | Generic drugs (ANDA) | July 1, 2009 |
| Aurobindo Pharma Limited | 1 | tablet | Generic drugs (ANDA) | September 23, 2016 |
| Aurobindo Pharma Limited | 1 | tablet | Generic drugs (ANDA) | January 6, 2023 |
| AvKARE | 1 | tablet | Generic drugs (ANDA) | June 18, 2013 |
| Mylan Pharmaceuticals Inc. | 1 | tablet | Generic drugs (ANDA) | July 12, 2013 |
| Naari Pte Limited | 1 | tablet | Generic drugs (ANDA) | May 31, 2024 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | November 3, 2010 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | November 11, 2020 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | April 18, 2018 |
| Teva Pharmaceuticals, Inc. | 1 | tablet | Authorized generics (NDA) | December 1, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 20 | 90.9% |
| Kit | 2 | 9.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 21 | 95.5% |
| Authorized generics (NDA) | 1 | 4.5% |
Pharmacologic classes
| Class | Products |
|---|---|
| Progestin | 20 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.